---
title: "RSSDI"
description: "RSSDI is India's Research Society for Study of Diabetes in India, publishing clinical guidelines for GLP-1 use."
canonical: "https://www.kesho.health/glossary/rssdi"
markdown_url: "https://www.kesho.health/md/glossary/rssdi"
language: "en-IN"
---

# RSSDI

**Canonical HTML:** https://www.kesho.health/glossary/rssdi  
**Markdown:** https://www.kesho.health/md/glossary/rssdi

## Definition

RSSDI (Research Society for Study of Diabetes in India) publishes evidence-based clinical practice recommendations for diabetes management in India.

## Extended

RSSDI guidelines position GLP-1 RAs for type 2 diabetes when metformin is insufficient, emphasising cardiorenal benefits and individualised therapy. Widely referenced by Indian diabetologists. In India, these concepts appear in RSSDI and ICMR guidance for type 2 diabetes and obesity care—always confirm details with your prescribing physician.

## Learn more

[Full guide](https://www.kesho.health/blog/glp-1-explained-india) · [MD](https://www.kesho.health/md/blog/glp-1-explained-india)

## Related terms

- [icmr](https://www.kesho.health/glossary/icmr)
- [type-2-diabetes](https://www.kesho.health/glossary/type-2-diabetes)
- [hba1c](https://www.kesho.health/glossary/hba1c)